July 18 (Reuters) - Shares of Australia's Ansell
ANN.AX slumped to the bottom of the benchmark index on Tuesday
after the medical gloves maker said it planned to temporarily
slow down output in fiscal 2024, hitting core profit for the
period.
Shares declined as much as 16% to A$23.320, marking their
biggest intraday percentage loss since January 31, 2022. They
were trading at A$23.72 as at 0209 GMT, their lowest level since
mid-July last year.
More than 1.5 million shares changed hands, compared with
the 30-day average of just over 314,000 shares.
Ansell, which gets 60% of its revenue from surgical,
single-use and examination gloves, said it will slow
manufacturing of finished goods to "normalise high inventory
levels," which will improve cash flow, but temporarily lower
core profit.
"While underlying end user demand for our surgical and Life
Sciences products is expected to continue to grow, we anticipate
that distributors will continue reducing their inventories, with
orders expected to increase towards the end of the fiscal year,"
the Victoria-based glove maker said in a statement.
Ansell will also aim to streamline its organisational
structure and reduce manufacturing employee numbers for the
investment program, it added.
(Reporting by Poonam Behura; Editing by Nivedita Bhattacharjee)
((Poonam.Behura@thomsonreuters.com;))